Medistim ASA (OSL:MEDI)

Market Cap	3.52B
Revenue (ttm)	562.60M
Net Income (ttm)	103.83M
Shares Out	18.31M
EPS (ttm)	5.67
PE Ratio	33.87
Forward PE	33.51
Dividend	6.00 (3.13%)
Ex-Dividend Date	Apr 25, 2024

Volume	11,437
Average Volume	52,994
Open	192.50
Previous Close	192.00
Day's Range	180.00 - 192.50
52-Week Range	130.00 - 204.00
Beta	0.88
RSI	77.38
Earnings Date	Feb 28, 2025

About Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Europe, Asia, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplan...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1984
• Employees: 151
• Stock Exchange: Oslo Børs
• Ticker Symbol: MEDI

Financial Performance

In 2024, Medistim ASA's revenue was 562.60 million, an increase of 7.96% compared to the previous year's 521.11 million. Earnings were 103.83 million, an increase of 0.01%.